Sfoglia per Autore
The immunogenicity of branded and biosimilar infliximab in rheumatoid arthritis according to Th9-related responses
2017 R. Talotta, A. Berzi, A. Doria, A. Batticciotto, M.C. Ditto, F. Atzeni, P. Sarzi-Puttini, D. Trabattoni
The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis
2017 F. Salaffi, M.C. Gerardi, F. Atzeni, A. Batticciotto, R. Talotta, A. Draghessi, M. Di Carlo, P. Sarzi-Puttini
An update on emerging drugs for fibromyalgia treatment
2017 F. Atzeni, M.C. Gerardi, I.F. Masala, A. Alciati, A. Batticciotto, P. Sarzi-Puttini
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
2018 R. Talotta, F. Atzeni, A. Batticciotto, M.C. Ditto, M.C. Gerardi, P. Sarzi-Puttini
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis : 52-Week Results from the CZP-SPEED Study
2018 P. Sarzi-Puttini, E. Filippucci, S. Adami, P.L. Meroni, A. Batticciotto, L. Idolazzi, O. De Lucia, P. Talavera, T. Kumke, W. Grassi
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes
2019 R. Talotta, V. Mercurio, S.F. Bongiovanni, C. Vittori, L. Boccassini, F. Rigamonti, A. Batticciotto, F. Atzeni, D. Trabattoni, P. Sarzi-Puttini, M. Biasin
Systemic rheumatic diseases : from biological agents to small molecules
2019 P. Sarzi-Puttini, A. Ceribelli, D. Marotto, A. Batticciotto, F. Atzeni
One year in review 2020: fibromyalgia
2020 L. Bazzichi, C. Giacomelli, A. Consensi, V. Giorgi, A. Batticciotto, M. Di Franco, P. Sarzi-Puttini
The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome
2021 F. Salaffi, V. Giorgi, S. Sirotti, S. Bongiovanni, S. Farah, L. Bazzichi, D. Marotto, F. Atzeni, M. Rizzi, A. Batticciotto, G. Lombardi, M. Galli, P. Sarzi-Puttini
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients
2021 F. Salaffi, M. Di Carlo, L. Bazzichi, F. Atzeni, M. Govoni, G. Biasi, M. Di Franco, F. Mozzani, E. Gremese, L. Dagna, A. Batticciotto, F. Fischetti, R. Giacomelli, S. Guiducci, G. Guggino, M. Bentivegna, R. Gerli, C. Salvarani, G. Bajocchi, M. Ghini, F. Iannone, V. Giorgi, S. Farah, M. Cirillo, S. Bonazza, S. Barbagli, C. Gioia, D. Santilli, A. Capacci, G. Cavalli, F. Carubbi, F. Nacci, I. Riccucci, L. Sinigaglia, M. Masullo, B. Polizzi, M. Cutolo, P. Sarzi-Puttini
Predictors, Risk Factors, and Incidence Rates of Psoriatic Arthritis Development in Psoriasis Patients: A Systematic Literature Review and Meta-Analysis
2021 A. Zabotti, O. De Lucia, G. Sakellariou, A. Batticciotto, G. Cincinelli, I. Giovannini, L. Idolazzi, G. Maioli, I. Tinazzi, D. Aletaha, S. De Vita, A. Marchesoni, J. Smolen, A. Iagnocco, D. Mcgonagle, R. Caporali
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile